DP VII ASSOCIATES LP Insider Trading Transactions
Get free email notifications about insider trading for DP VII ASSOCIATES LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DP VII ASSOCIATES LP. DP VII ASSOCIATES LP is 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in CADENCE PHARMACEUTICALS INC ($CADX) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in OBALON THERAPEUTICS INC ($OBLN) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in TANDEM DIABETES CARE INC ($TNDM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Neothetics, Inc. ($NEOT).
Latest Insider Trading Transactions of DP VII ASSOCIATES LP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, CADX, CLVS, ESPR, NEOT, EVOK, OREX, OBLN, TNDM, TBRA, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 03 2016 | TBRA | Tobira Therapeutic ... | DP VII ASSOCIATES LP | 10% Owner | Sell | U | 28.35 | 47,613 | 1,349,829 | 0 | 47.6 K to 0 (-100.00 %) |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 14,271 | 0 | 0 | |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 20,583 | 0 | 0 | |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 11,083 | 0 | 0 | |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 49,570 | 0 | 49,570 | 0 to 49.6 K |
May 27 2016 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 4.70 | 5,880 | 27,636 | 10,328 | 16.2 K to 10.3 K (-36.28 %) |
Apr 27 2016 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.02 | 61 | 306 | 16,208 | 16.3 K to 16.2 K (-0.37 %) |
Apr 27 2016 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.20 | 21 | 109 | 16,269 | 16.3 K to 16.3 K (-0.13 %) |
Apr 21 2016 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.29 | 76 | 402 | 16,290 | 16.4 K to 16.3 K (-0.46 %) |
Apr 21 2016 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.36 | 632 | 3,388 | 16,366 | 17 K to 16.4 K (-3.72 %) |
Apr 13 2016 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.22 | 75 | 392 | 16,998 | 17.1 K to 17 K (-0.44 %) |
Apr 08 2016 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.35 | 251 | 1,343 | 17,073 | 17.3 K to 17.1 K (-1.45 %) |
Apr 08 2016 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.26 | 475 | 2,499 | 17,324 | 17.8 K to 17.3 K (-2.67 %) |
Apr 08 2016 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.22 | 148 | 773 | 17,799 | 17.9 K to 17.8 K (-0.82 %) |
Aug 20 2015 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 7.02 | 202 | 1,418 | 17,947 | 18.1 K to 17.9 K (-1.11 %) |
Apr 16 2015 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 7.07 | 554 | 3,917 | 18,149 | 18.7 K to 18.1 K (-2.96 %) |
Apr 16 2015 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 7.58 | 135 | 1,023 | 18,703 | 18.8 K to 18.7 K (-0.72 %) |
Apr 16 2015 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 7.78 | 168 | 1,307 | 18,838 | 19 K to 18.8 K (-0.88 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | M | 8.54 | 2,827 | 24,143 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | M | 8.54 | 1,570 | 13,408 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 102,282 | 0 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 36,913 | 0 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 104,247 | 0 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 12,578 | 0 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Payment of Exercise | F | 14.00 | 1,725 | 24,150 | 48,023 | 49.7 K to 48 K (-3.47 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Buy | M | 8.54 | 2,827 | 24,143 | 49,748 | 46.9 K to 49.7 K (+6.03 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Payment of Exercise | F | 14.00 | 958 | 13,412 | 46,921 | 47.9 K to 46.9 K (-2.00 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Buy | M | 8.54 | 1,570 | 13,408 | 47,879 | 46.3 K to 47.9 K (+3.39 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 46,309 | 0 | 46,309 | 0 to 46.3 K |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | D | 14.00 | 50,743 | 710,402 | 0 | 50.7 K to 0 (-100.00 %) |
Feb 14 2014 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | M | 7.84 | 23,317 | 182,805 | 0 | |
Feb 14 2014 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Payment of Exercise | F | 14.00 | 13,058 | 182,812 | 50,743 | 63.8 K to 50.7 K (-20.47 %) |
Feb 14 2014 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Buy | M | 7.84 | 23,317 | 182,805 | 63,801 | 40.5 K to 63.8 K (+57.60 %) |
Mar 17 2014 | AKAO | Achaogen Inc | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 7,430 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 15,799 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 10,661 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 33,890 | 0 | 33,890 | 0 to 33.9 K |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | J | 7.37 | 6,008 | 44,279 | 6,008 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | J | 4.40 | 10,068 | 44,299 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 38,941 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 9,378 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 6,071 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 54,390 | 0 | 54,390 | 0 to 54.4 K |
Sep 30 2013 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 19,006 | 0 | 0 | |
Sep 30 2013 | EVOK | Evoke Pharma Inc | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 19,006 | 0 | 19,006 | 0 to 19 K |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | J | 6.99 | 1,193 | 8,339 | 1,193 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | J | 1.00 | 8,346 | 8,346 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 30,462 | 0 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 14.00 | 4,791 | 67,074 | 35,253 | 30.5 K to 35.3 K (+15.73 %) |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 30,462 | 0 | 30,462 | 0 to 30.5 K |
Jun 05 2013 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 64.58 | 2,779 | 179,468 | 44,034 | 46.8 K to 44 K (-5.94 %) |
Mar 06 2013 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 24.51 | 1,651 | 40,466 | 46,813 | 48.5 K to 46.8 K (-3.41 %) |
Mar 06 2013 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 24.69 | 2,132 | 52,639 | 48,464 | 50.6 K to 48.5 K (-4.21 %) |
Mar 06 2013 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 24.44 | 417 | 10,191 | 50,596 | 51 K to 50.6 K (-0.82 %) |
Mar 22 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.49 | 893 | 4,903 | 40,484 | 41.4 K to 40.5 K (-2.16 %) |
Mar 21 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.22 | 92 | 480 | 41,377 | 41.5 K to 41.4 K (-0.22 %) |
Mar 21 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.19 | 134 | 695 | 41,469 | 41.6 K to 41.5 K (-0.32 %) |
Mar 19 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.16 | 135 | 697 | 41,603 | 41.7 K to 41.6 K (-0.32 %) |
Mar 19 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.28 | 163 | 861 | 41,738 | 41.9 K to 41.7 K (-0.39 %) |
Mar 15 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.36 | 85 | 456 | 41,901 | 42 K to 41.9 K (-0.20 %) |
Mar 15 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.40 | 131 | 707 | 41,986 | 42.1 K to 42 K (-0.31 %) |
Mar 13 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.38 | 107 | 576 | 42,117 | 42.2 K to 42.1 K (-0.25 %) |
Mar 13 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.34 | 70 | 374 | 42,224 | 42.3 K to 42.2 K (-0.17 %) |
Mar 11 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.32 | 88 | 468 | 42,294 | 42.4 K to 42.3 K (-0.21 %) |
Mar 11 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.22 | 215 | 1,122 | 42,382 | 42.6 K to 42.4 K (-0.50 %) |
Mar 05 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.01 | 88 | 441 | 42,731 | 42.8 K to 42.7 K (-0.21 %) |
Mar 05 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.01 | 130 | 651 | 42,819 | 42.9 K to 42.8 K (-0.30 %) |
Mar 07 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.06 | 65 | 329 | 42,597 | 42.7 K to 42.6 K (-0.15 %) |
Mar 07 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.01 | 69 | 346 | 42,662 | 42.7 K to 42.7 K (-0.16 %) |
Feb 22 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.01 | 34 | 170 | 42,949 | 43 K to 42.9 K (-0.08 %) |
Feb 20 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.02 | 171 | 858 | 42,983 | 43.2 K to 43 K (-0.40 %) |
Feb 20 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.00 | 51 | 255 | 43,154 | 43.2 K to 43.2 K (-0.12 %) |
Feb 15 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.01 | 51 | 256 | 43,205 | 43.3 K to 43.2 K (-0.12 %) |
Feb 15 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.00 | 98 | 490 | 43,256 | 43.4 K to 43.3 K (-0.23 %) |
Feb 05 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 4.85 | 164 | 795 | 43,354 | 43.5 K to 43.4 K (-0.38 %) |
Feb 01 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 4.71 | 314 | 1,479 | 43,518 | 43.8 K to 43.5 K (-0.72 %) |
Feb 01 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.00 | 188 | 940 | 43,832 | 44 K to 43.8 K (-0.43 %) |
Jan 30 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.27 | 260 | 1,370 | 44,020 | 44.3 K to 44 K (-0.59 %) |
Jan 30 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.40 | 282 | 1,523 | 44,280 | 44.6 K to 44.3 K (-0.63 %) |
Jan 28 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.38 | 234 | 1,259 | 44,562 | 44.8 K to 44.6 K (-0.52 %) |
Jan 28 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.45 | 616 | 3,357 | 44,796 | 45.4 K to 44.8 K (-1.36 %) |
Jan 24 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.11 | 430 | 2,197 | 45,412 | 45.8 K to 45.4 K (-0.94 %) |
Jan 24 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.02 | 254 | 1,275 | 45,842 | 46.1 K to 45.8 K (-0.55 %) |
Jan 22 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.19 | 324 | 1,682 | 46,096 | 46.4 K to 46.1 K (-0.70 %) |
Jan 22 2013 | CADX | CADENCE PHARMACEUT ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 5.35 | 214 | 1,145 | 46,420 | 46.6 K to 46.4 K (-0.46 %) |
Dec 22 2011 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | P | 0.00 | 7,882 | 8 | 7,882 | |
Dec 22 2011 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 1.45 | 7,882 | 11,429 | 50,643 | 42.8 K to 50.6 K (+18.43 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Sep 20 2011 | ZGNX | ZOGENIX, INC. | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 2.00 | 58,696 | 117,392 | 169,251 | 110.6 K to 169.3 K (+53.09 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 14,903 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 21,027 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 35,215 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 4.00 | 39,410 | 157,640 | 110,555 | 71.1 K to 110.6 K (+55.39 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 14,903 | 0 | 71,145 | 56.2 K to 71.1 K (+26.50 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 21,027 | 0 | 56,242 | 35.2 K to 56.2 K (+59.71 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 35,215 | 0 | 35,215 | 0 to 35.2 K |
Dec 21 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 7.50 | 639 | 4,793 | 42,761 | 42.1 K to 42.8 K (+1.52 %) |
Dec 21 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 7.55 | 1,677 | 12,661 | 42,122 | 40.4 K to 42.1 K (+4.15 %) |
Nov 25 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 6.75 | 839 | 5,663 | 40,445 | 39.6 K to 40.4 K (+2.12 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 6.93 | 2,516 | 17,436 | 39,606 | 37.1 K to 39.6 K (+6.78 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 6.93 | 4,192 | 29,051 | 37,090 | 32.9 K to 37.1 K (+12.74 %) |
Nov 16 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 6.90 | 1,040 | 7,176 | 32,898 | 31.9 K to 32.9 K (+3.26 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 6.93 | 899 | 6,230 | 31,858 | 31 K to 31.9 K (+2.90 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 6.93 | 1,415 | 9,806 | 30,959 | 29.5 K to 31 K (+4.79 %) |
Aug 19 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 7.73 | 231 | 1,786 | 29,544 | 29.3 K to 29.5 K (+0.79 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 7.64 | 1,060 | 8,098 | 29,313 | 28.3 K to 29.3 K (+3.75 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 8.00 | 440 | 3,520 | 28,253 | 27.8 K to 28.3 K (+1.58 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 7.85 | 218 | 1,711 | 27,813 | 27.6 K to 27.8 K (+0.79 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 8.00 | 6,708 | 53,664 | 27,595 | 20.9 K to 27.6 K (+32.12 %) |
Aug 13 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 7.60 | 1,749 | 13,292 | 20,887 | 19.1 K to 20.9 K (+9.14 %) |
Jul 24 2009 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 7.50 | 10,901 | 81,758 | 19,138 | 8.2 K to 19.1 K (+132.34 %) |
Dec 11 2008 | OREX | Orexigen Therapeut ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 4.93 | 4,064 | 20,036 | 8,237 | 4.2 K to 8.2 K (+97.39 %) |
Page: 1